暂无中文版
该报道尚无中文版，以下为英文内容。
低影响
FDA approved Moderna's updated 2026-2027 COVID-19 vaccines, including mRNA-1345 (Mnexspike) for a new formula and Spikevax for the 2026-2027 formula.
FirstSquawk08/28 03:05
Moderna announced FDA approval for its updated 2026-2027 COVID-19 vaccines, including MNexspike with a new formula and Spikevax for the 2026-2027 formula.